Caxfila-160 Tablet is utilized as a symptomatic treatment for individuals diagnosed with breast cancer and endometrial cancer.
Breast cancer originates in the breast cells and is marked by a lump in the breast, alterations in the shape of the nipple or breast, and bloody discharge from the nipples.
Caxfila-160 Tablet contains ‘Megestrol’, which disrupts the production or function of hormones that contribute to cancer growth. This mechanism aids in slowing the advancement of cancer and alleviating the symptoms related to it.
Common side effects associated with Caxfila-160 Tablet include an increased appetite, weight gain, shortness of breath, hot flashes, elevated blood pressure, heightened blood sugar levels, a rounded face, constipation, and swelling of a vein due to a blood clot. Should any of these side effects persist or worsen, please notify your doctor immediately.
Avoid taking Caxfila-160 Tablet if you have an allergy to Megestrol or any of its components. Prior to using Caxfila-160 Tablet, inform your doctor if you have severe liver issues, a history of thrombophlebitis (blood clots), stroke, adrenal gland disorders, or diabetes. Caxfila-160 Tablet is not advised for children, pregnant women, or nursing mothers.
